Annual CFO
-$8.21 M
-$199.00 K-2.49%
01 December 2023
Summary:
Artelo Biosciences annual cash flow from operations is currently -$8.21 million, with the most recent change of -$199.00 thousand (-2.49%) on 01 December 2023. During the last 3 years, it has fallen by -$5.54 million (-207.72%). ARTL annual CFO is now -60692.59% below its all-time high of -$13.50 thousand, reached on 31 August 2015.ARTL Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$778.00 K
+$1.28 M+62.29%
01 September 2024
Summary:
Artelo Biosciences quarterly cash flow from operations is currently -$778.00 thousand, with the most recent change of +$1.28 million (+62.29%) on 01 September 2024. Over the past year, it has increased by +$1.82 million (+70.03%).ARTL Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$8.38 M
+$1.02 M+10.89%
01 September 2024
Summary:
Artelo Biosciences TTM cash flow from operations is currently -$8.38 million, with the most recent change of +$1.02 million (+10.89%) on 01 September 2024. Over the past year, it has dropped by -$172.00 thousand (-2.10%). ARTL TTM CFO is now -1675700.00% below its all-time high of -$500.00, reached on 30 November 2014.ARTL TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARTL Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +70.0% | -2.1% |
| 3 y3 years | -207.7% | - | - |
| 5 y5 years | -193.9% | +26.0% | -143.3% |
ARTL Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -207.7% | at low | at high | +73.6% | -14.8% | +10.9% |
| 5 y | 5 years | -207.7% | at low | at high | +73.6% | -143.3% | +10.9% |
| alltime | all time | <-9999.0% | at low | <-9999.0% | +73.6% | <-9999.0% | +10.9% |
Artelo Biosciences Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$778.00 K(-62.3%) | -$8.38 M(-10.9%) |
| June 2024 | - | -$2.06 M(-29.9%) | -$9.40 M(+4.9%) |
| Mar 2024 | - | -$2.94 M(+13.3%) | -$8.96 M(+9.2%) |
| Dec 2023 | -$8.21 M(+2.5%) | -$2.60 M(+44.1%) | -$8.21 M(+3.8%) |
| Sept 2023 | - | -$1.80 M(+11.0%) | -$7.90 M(+1.4%) |
| June 2023 | - | -$1.62 M(-25.8%) | -$7.80 M(-4.2%) |
| Mar 2023 | - | -$2.19 M(-4.7%) | -$8.14 M(+1.7%) |
| Dec 2022 | -$8.01 M(+200.3%) | -$2.29 M(+35.2%) | -$8.01 M(+4.8%) |
| Sept 2022 | - | -$1.70 M(-13.7%) | -$7.64 M(+2.1%) |
| June 2022 | - | -$1.97 M(-4.2%) | -$7.49 M(+2.5%) |
| Mar 2022 | - | -$2.05 M(+6.6%) | -$7.30 M(+8.2%) |
| Dec 2021 | -$2.67 M(-56.6%) | - | - |
| Nov 2021 | - | -$1.93 M(+25.0%) | -$6.75 M(+9.9%) |
| Aug 2021 | -$6.14 M(+41.3%) | -$1.54 M(-13.4%) | -$6.14 M(+12.2%) |
| May 2021 | - | -$1.78 M(+18.8%) | -$5.47 M(+16.1%) |
| Feb 2021 | - | -$1.50 M(+13.6%) | -$4.71 M(+2.1%) |
| Nov 2020 | - | -$1.32 M(+51.3%) | -$4.62 M(+6.2%) |
| Aug 2020 | -$4.35 M(+55.7%) | -$872.30 K(-14.5%) | -$4.35 M(-4.2%) |
| May 2020 | - | -$1.02 M(-27.2%) | -$4.54 M(+10.5%) |
| Feb 2020 | - | -$1.40 M(+33.4%) | -$4.10 M(+19.2%) |
| Nov 2019 | - | -$1.05 M(-0.9%) | -$3.44 M(+23.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Aug 2019 | -$2.79 M(+73.5%) | -$1.06 M(+80.0%) | -$2.79 M(+24.4%) |
| May 2019 | - | -$589.50 K(-20.4%) | -$2.25 M(+6.2%) |
| Feb 2019 | - | -$741.00 K(+84.7%) | -$2.11 M(+14.9%) |
| Nov 2018 | - | -$401.20 K(-21.9%) | -$1.84 M(+14.4%) |
| Aug 2018 | -$1.61 M(+642.6%) | -$513.90 K(+12.0%) | -$1.61 M(+28.4%) |
| May 2018 | - | -$458.80 K(-1.9%) | -$1.25 M(+50.7%) |
| Feb 2018 | - | -$467.50 K(+175.2%) | -$832.10 K(+122.2%) |
| Nov 2017 | - | -$169.90 K(+7.5%) | -$374.40 K(+72.6%) |
| Aug 2017 | -$216.80 K(+1071.9%) | -$158.00 K(+330.5%) | -$216.90 K(+268.3%) |
| May 2017 | - | -$36.70 K(+274.5%) | -$58.90 K(+125.7%) |
| Feb 2017 | - | -$9800.00(-21.0%) | -$26.10 K(+56.3%) |
| Nov 2016 | - | -$12.40 K(<-9900.0%) | -$16.70 K(-10.2%) |
| Aug 2016 | -$18.50 K(+37.0%) | $0.00(-100.0%) | -$18.60 K(-13.5%) |
| May 2016 | - | -$3900.00(+875.0%) | -$21.50 K(-0.5%) |
| Feb 2016 | - | -$400.00(-97.2%) | -$21.60 K(-21.2%) |
| Nov 2015 | - | -$14.30 K(+393.1%) | -$27.40 K(+101.5%) |
| Aug 2015 | -$13.50 K(-11.8%) | -$2900.00(-27.5%) | -$13.60 K(+27.1%) |
| May 2015 | - | -$4000.00(-35.5%) | -$10.70 K(+59.7%) |
| Feb 2015 | - | -$6200.00(+1140.0%) | -$6700.00(+1240.0%) |
| Nov 2014 | - | -$500.00 | -$500.00 |
| Aug 2014 | -$15.30 K | - | - |
FAQ
- What is Artelo Biosciences annual cash flow from operations?
- What is the all time high annual CFO for Artelo Biosciences?
- What is Artelo Biosciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for Artelo Biosciences?
- What is Artelo Biosciences quarterly CFO year-on-year change?
- What is Artelo Biosciences TTM cash flow from operations?
- What is the all time high TTM CFO for Artelo Biosciences?
- What is Artelo Biosciences TTM CFO year-on-year change?
What is Artelo Biosciences annual cash flow from operations?
The current annual CFO of ARTL is -$8.21 M
What is the all time high annual CFO for Artelo Biosciences?
Artelo Biosciences all-time high annual cash flow from operations is -$13.50 K
What is Artelo Biosciences quarterly cash flow from operations?
The current quarterly CFO of ARTL is -$778.00 K
What is the all time high quarterly CFO for Artelo Biosciences?
Artelo Biosciences all-time high quarterly cash flow from operations is $0.00
What is Artelo Biosciences quarterly CFO year-on-year change?
Over the past year, ARTL quarterly cash flow from operations has changed by +$1.82 M (+70.03%)
What is Artelo Biosciences TTM cash flow from operations?
The current TTM CFO of ARTL is -$8.38 M
What is the all time high TTM CFO for Artelo Biosciences?
Artelo Biosciences all-time high TTM cash flow from operations is -$500.00
What is Artelo Biosciences TTM CFO year-on-year change?
Over the past year, ARTL TTM cash flow from operations has changed by -$172.00 K (-2.10%)